"Geographic Atrophy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of MACULAR DEGENERATION also known as dry macular degeneration marked by occurrence of a well-defined progressive lesion or atrophy in the central part of the RETINA called the MACULA LUTEA. It is distinguishable from WET MACULAR DEGENERATION in that the latter involves neovascular exudates.
| Descriptor ID |
D057092
|
| MeSH Number(s) |
C11.768.585.439.122
|
| Concept/Terms |
Geographic Atrophy- Geographic Atrophy
- Atrophies, Geographic
- Atrophy, Geographic
- Geographic Atrophies
- Dry Macular Degeneration
- Degeneration, Dry Macular
- Degenerations, Dry Macular
- Dry Macular Degenerations
- Macular Degeneration, Dry
- Macular Degenerations, Dry
|
Below are MeSH descriptors whose meaning is more general than "Geographic Atrophy".
Below are MeSH descriptors whose meaning is more specific than "Geographic Atrophy".
This graph shows the total number of publications written about "Geographic Atrophy" by people in this website by year, and whether "Geographic Atrophy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 0 | 2 |
| 2019 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 2 | 0 | 2 |
| 2023 | 8 | 0 | 8 |
| 2024 | 2 | 0 | 2 |
| 2025 | 3 | 0 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Geographic Atrophy" by people in Profiles.
-
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. BMJ Open Ophthalmol. 2025 Jul 07; 10(1).
-
Pegcetacoplan for Geographic Atrophy Over 30 Months: Data From OAKS, DERBY, and the GALE Long-Term Extension Study. Ophthalmic Surg Lasers Imaging Retina. 2025 Jul; 56(7):398-406.
-
Pegcetacoplan Treatment for Geographic Atrophy in Age-Related Macular Degeneration Over 36 Months: Data From OAKS, DERBY, and GALE. Am J Ophthalmol. 2025 Aug; 276:350-364.
-
Favorable Outcome After Pegcetacoplan (Syfovre)-Associated Occlusive Retinal Vasculitis. Ophthalmic Surg Lasers Imaging Retina. 2025 Mar; 56(3):170-173.
-
Quantifying Geographic Atrophy in Age-Related Macular Degeneration: A Comparative Analysis Across 12 Deep Learning Models. Invest Ophthalmol Vis Sci. 2024 Jul 01; 65(8):42.
-
Syfovre Approval for Geographic Atrophy. JAMA Ophthalmol. 2024 Jul 01; 142(7):685-686.
-
Topographic analysis of local OCT biomarkers which predict progression to atrophy in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2024 Jul; 262(7):2083-2091.
-
Therapies for Geographic Atrophy. Int Ophthalmol Clin. 2024 Jan 01; 64(1):5-20.
-
Imaging Modalities for Dry Macular Degeneration. Int Ophthalmol Clin. 2024 Jan 01; 64(1):35-55.
-
The effect of complement C3 or C5 inhibition on geographic atrophy secondary to age-related macular degeneration: A living systematic review and meta-analysis. Surv Ophthalmol. 2024 May-Jun; 69(3):349-361.